SAB Biotherapeutics, Inc. is a clinical stage biopharmaceutical company developing and delivering natural, life-saving immunotherapies that have the potential to transform the prevention and treatment of diseases from Ebola to cancer, and diabetes to influenza.
For more information visit: www.sabbiotherapeutics.com
Alumend is a privately held biotech firm developing innovative medical products based on a platform tissue bonding technology. Products target the tissue adhesive and sealant industry, dermatology, neurology and vascular surgery. This technology will also be leveraged for local drug delivery and bulking/reconstructive surgery applications.